# Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer

> **NCT00931450** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Institut Català d'Oncologia** · enrollment: 70 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** exemestane
- **DRUG:** sunitinib malate
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00931450
- **Lead sponsor:** Institut Català d'Oncologia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2011-10
- **Final completion:** —
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2013-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931450, "Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00931450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*